Immersive Nature-Based Wellbeing Program in Older Adults With Cognitive Impairment (COGNITIO)
Cognitio Avançada: Immersive Nature-Based Wellbeing Program for Older Adults With Cognitive Impairment: A Quasi-Experimental Pre-Post Study
This study aims to evaluate an immersive virtual reality program designed to support cognitive and emotional well-being in older adults with mild to moderate cognitive impairment. The program uses nature-based environments combined with mindfulness, cognitive stimulation, and breathing techniques. The goal is to determine whether immersive virtual reality can be a safe and effective tool to improve well-being and support active and healthy aging.
The study will be conducted in two phases. In the first phase, virtual environments will be tested in healthy participants using behavioral and physiological measures. In the second phase, 200 older adults with cognitive impairment from day care centers and residential facilities will participate in a group-based immersive virtual reality intervention consisting of 10 sessions.
Researchers will assess changes in cognitive function, emotional wellbeing, daily functioning, and quality of life before and after the intervention.
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
상세 설명
This study evaluates the effectiveness of an immersive virtual reality program based on nature environments to improve cognitive function, emotional well-being, functional ability, and quality of life in older adults with mild to moderate cognitive impairment.
Cognitive impairment is common in older adults and can negatively affect independence, emotional well-being, and quality of life. Non-pharmacological interventions using emerging technologies, such as immersive virtual reality, offer new opportunities to support cognitive and emotional health. Nature-based virtual environments may help reduce stress, improve mood, and increase engagement, even in individuals with limited mobility or access to natural settings.
The study takes place across services affiliated with Suara Cooperativa. In Phase 1, researchers test and validate immersive virtual environments in healthy participants. Participants attend individual sessions where they view nature-based virtual scenarios. Researchers collect behavioral, subjective, and physiological data, including electroencephalography, heart rate, electrodermal activity, and respiration, to assess safety, usability, and emotional responses to the virtual environments.
In Phase 2, researchers conduct a quasi-experimental pre-post study without a control group. The study includes 200 participants (100 with mild cognitive impairment and 100 with moderate cognitive impairment) recruited from day care centers and residential facilities managed by Suara Cooperativa.
Participants take part in a structured group-based intervention consisting of 10 immersive virtual reality sessions. The program combines exposure to nature-based virtual environments with mindfulness practices, cognitive stimulation activities, and breathing techniques to promote emotional regulation and cognitive engagement. The intervention is accessible, engaging, and adapted to the needs of older adults with cognitive impairment.
Primary outcome measures include cognitive function, emotional well-being, functional capacity in activities of daily living, and quality of life. Researchers also assess participant engagement and acceptability of the intervention as secondary measures.
Researchers analyze data using descriptive and inferential statistical methods to assess changes between pre- and post-intervention measures. They also evaluate adherence to the intervention and participant satisfaction.
This study aims to generate evidence on the potential of immersive virtual reality as an innovative, safe, and accessible non-pharmacological intervention to support cognitive health, emotional well-being, and autonomy in older adults, contributing to active and healthy aging.
연구 유형
연구 유형
등록 (추정된)
등록
단계
단계
- 해당 없음
연락처 및 위치
연구 연락처
연구 연락처
- 이름: Maite Garolera, PhD
- 전화번호: 1558 +34937310007
- 이메일: mgarolera@cst.cat
연구 장소
-
-
Barcelona
-
Terrassa, Barcelona, 스페인, 08227
- 모병
- Consorci Sanitari de Terrassa
-
연락하다:
- Maite Garolera, PhD
- 전화번호: 1758 +34937310007
- 이메일: mgarolera@cst.cat
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
- 고령자
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria:
- Age ≥ 65 years
- Diagnosis of mild or moderate cognitive impairment
- Ability to understand study procedures and follow instructions
- Ability to provide informed consent (or consent provided by a legal representative)
- Attendance at participating day care centers or residential facilities (Phase 2)
- For Phase 1: healthy adults without cognitive impairment
Exclusion Criteria:
- Severe cognitive impairment or diagnosis of advanced dementia
- Severe visual, auditory, or motor impairments that prevent use of virtual reality
- Neurological or psychiatric conditions that may interfere with participation
- History of epilepsy or conditions contraindicating virtual reality exposure
- Severe behavioral disturbances or agitation
- Participation in other clinical studies that may interfere with results
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 방지
- 할당: 해당 없음
- 중재 모델: 단일 그룹 할당
- 마스킹: 없음(오픈 라벨)
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
실험적: Immersive virtual reality intervention
Participants receive a group-based immersive virtual reality intervention consisting of 10 sessions using nature-based environments combined with mindfulness, cognitive stimulation, and breathing techniques.
|
Participants receive an immersive virtual reality intervention using nature-based environments.
The program consists of 10 group sessions that combine mindfulness, cognitive stimulation, and breathing techniques to promote cognitive and emotional well-being.
|
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in cognitive function (verbal fluency and Digit Span tests)
기간: Baseline (pre-intervention) and immediately post-intervention (1 week)
|
Cognitive function is assessed using verbal fluency tasks and Digit Span tests (forward and backward).
Verbal fluency evaluates language and executive function by measuring the number of words generated under specific conditions.
Digit Span forward assesses attention, while Digit Span backward assesses working memory.
Higher scores indicate better cognitive performance.
|
Baseline (pre-intervention) and immediately post-intervention (1 week)
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in anxiety symptoms (Generalized Anxiety Disorder 7-item scale [GAD-7])
기간: Baseline (pre-intervention) and immediately post-intervention (1 week)
|
Anxiety symptoms are assessed using the GAD-7 questionnaire, a validated self-report scale measuring severity of generalized anxiety symptoms.
Higher scores indicate greater anxiety.
|
Baseline (pre-intervention) and immediately post-intervention (1 week)
|
|
Short-form Yesavage Geriatric Depression Scale (GDS-SF)
기간: Baseline (pre-intervention) and immediately post-intervention (1 week)
|
Depressive symptoms are assessed using the GDS-SF, a validated screening tool for depression in older adults.
Higher scores indicate greater depressive symptomatology.
|
Baseline (pre-intervention) and immediately post-intervention (1 week)
|
|
Change in positive and negative affect (Positive and Negative Affect Schedule-10 [PANAS-10])
기간: Baseline (pre-intervention) and immediately post-intervention (1 week)
|
Affective state is assessed using the PANAS-10, which measures positive and negative affect.
Higher scores reflect higher levels of the corresponding affect.
|
Baseline (pre-intervention) and immediately post-intervention (1 week)
|
|
Change in loneliness (UCLA Loneliness Scale, UCLA-10)
기간: Baseline (pre-intervention) and immediately post-intervention (1 week)
|
Loneliness is assessed using the UCLA-10 scale, a validated self-report measure of perceived social isolation.
Higher scores indicate greater loneliness.
|
Baseline (pre-intervention) and immediately post-intervention (1 week)
|
|
Change in quality of life (EuroQol 5-Dimension 5-Level questionnaire [EQ-5D-5L])
기간: Baseline (pre-intervention) and immediately post-intervention (1 week)
|
Quality of life is assessed using the EuroQol-5D-5L questionnaire, which evaluates health status across five dimensions.
Higher index values indicate better perceived health-related quality of life.
|
Baseline (pre-intervention) and immediately post-intervention (1 week)
|
|
Change in functional ability (Bayer Activities of Daily Living Scale [BAYER-ADL])
기간: Baseline (pre-intervention) and immediately post-intervention (1 week)
|
Functional ability is assessed using the Bayer Activities of Daily Living Scale, which measures impairments in instrumental activities of daily living.
Higher scores indicate greater functional impairment.
|
Baseline (pre-intervention) and immediately post-intervention (1 week)
|
기타 결과 측정
기타 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Perceived immersion during virtual reality sessions (Self-Assessment Manikin, SAM)
기간: At the end of virtual reality sessions 4, 7, and 10, during the 1-week intervention period.
|
Immersion is assessed using the Self-Assessment Manikin (SAM), a non-verbal pictorial tool that captures participants' subjective experience during exposure to immersive virtual environments.
|
At the end of virtual reality sessions 4, 7, and 10, during the 1-week intervention period.
|
|
Participant satisfaction with immersive virtual reality sessions
기간: At the end of virtual reality sessions 4, 7, and 10, during the 1-week intervention period.
|
Satisfaction is assessed using an ad hoc questionnaire evaluating participants' experience, acceptability, and perceived usefulness of the intervention.
|
At the end of virtual reality sessions 4, 7, and 10, during the 1-week intervention period.
|
|
Intervention adherence based on session attendance and completion rates
기간: At the end of each intervention day: Day 1 (after session 4), Day 2 (after session 7), and Day 3 (after session 10).
|
Adherence is measured by attendance rate and completion of the scheduled sessions.
|
At the end of each intervention day: Day 1 (after session 4), Day 2 (after session 7), and Day 3 (after session 10).
|
공동 작업자 및 조사자
협력자
협력자
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
기타 연구 ID 번호
- DDS027/24/000611
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .